Bromination from the macroscopic level to the tracer radiochemical level:76Br radiolabeling of aromatic compounds via electrophilic substitution

Bioconjugate Chemistry

Volumn 20, Issue 4, 2009, Pages 808-816

  Zhou, Dong ^a   Zhou, Haibing ^b,c   Jenks, Carl C ^a   Lewis, Jason S ^a,d   Katzenellenbogen, John A ^b   Welch, Michael J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c WUHAN UNIVERSITY   (China)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (5 ACETOXY 7 BROMOBENZOXAZOL 2 YL)PHENYL ACETATE BR 76; AROMATIC COMPOUND; BROMINE 76; ELECTROPHILE; HYDROGEN PEROXIDE; METHANOL; PERACETIC ACID; RADIOPHARMACEUTICAL AGENT; SOLVENT; UNCLASSIFIED DRUG; WATER;

ARTICLE; BROMINATION; DRUG SYNTHESIS; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY;

EID: 65249159021     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc800313c     Document Type: Article

References (43)

1. For reviews, see: Handbook of Radiopharmaceuticals (2003) (Welch, M. J., and Redvanly, C. S., Eds.) John Wiley & Sons Ltd., New York.
2. +-emitting compounds based on fluorine-18. Toy. Curr. Chem. 222, 201-258.
3. Bolton, R. (2002) Radiohalogen incorporation into organic systems. J. Label. Comyd. Radioyharm. 45, 485-528.
4. Seevers, R. H., and Counsell, R. E. (1982) Radioiodination techniques for small organic molecules. Chem. Rev.82, 575-590.
5. Eisenhut, M., and Mier, W. (2004) Radioiodination Chemistry and Radioiodinated Compounds. Handbook of Nuclear Chemistry. Volume 4: Radiochemistry and Radiopharmaceutical Chemistry in Life Sciences (Vértes, A., Nagy, S., and Klencsár, Z., Eds.) pp 257-278, Chapter 7, Springer, New York.
6. Coenen, H. H., Moerlein, S. M., and Stoecklin, G. (1983) No-carrier added radiohalogenation methods with heavy halogens. Radiochim. Acta 34, 47-68.
7. Maziere, B., and Loc'h, C. (1986) Radiopharmaceuticals labelled with bromine isotopes. Ayyl. Radiat. Isot. 37, 703-713.
8. Rowland, D. J., McCarthy, T. J., and Welch, M. J. (2003) Radiobromine for imaging and therapy. Handbook of Radiopharmaceuticals (Welch, M. J., and Redvanly, C. S., Eds.) pp 441-65, Chapter 14, John Wiley & Sons Ltd., New York.
9. Radiopharmaceuticals for Positron Emission Tomography (1993) (Stöcklin, G., and Pike, V. W., Eds.) p 3, Springer, New York.
10. 76Br by a low-energy cyclotron. Appl. Radiat. Isot. 49, 1537-1540.
11. Malamas, M. S., Manas, E. S., McDevitt, R. E., Gunawan, I., Xu, Z. B., Collini, M. D., Miller, C. P., Dinh, T., Henderson, R. A., Jr., and Harris, H. A. (2004) Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor ligands. J. Med. Chem. 47, 5021-5040.
12. Harris, H. A., Albert, L. M., Leathurby, Y., Malamas, M. S., Mewshaw, R. E., Miller, C. P., Kharode, Y. P., Marzolf, J., Komm, B. S., Winneker, R. C., Frail, D. E., Henderson, R. A., Zhu, Y., and Keith, J. C., Jr. (2003) Evaluation of an estrogen receptor-β agonist in animal models of human disease. Endocrinology 144, 4241-4249.
13. Denat, F., Gaspard-Iloughmane, H., and Dubac, J. (1992) An easy one-pot synthesis of group 14 C-metallated 2(or 3)-furan-and thiophenecarbaldehydes. Synthesis 10, 954-956.
14. Tang, L. (2008) Radionuclide production and yields at Washington University School of Medicine. O. J. Nucl. Med. Mol. Imagins 52, 121-133.
15. Petzold, G., and Coenen, H. H. (1981) Chloramine-T for no-carrier-added labelling of aromatic biomolecules with bromine-75, 77. J. Label. Compd. Radiopharm. 18, 1319-1336.
16. Suehiro, M., Iwamoto, M., Arai, I., and Nozaki, T. (1990) Bromination, no-carrier-added radiobromination and simultaneously occurring chlorination by chloramine-T. Appl. Radiat. Isot. 41, 439-447.
17. 77Br]bromoestradiol-17 beta: a high specific-activity, gamma-emitting tracer with uptake in rat uterus and uterus and induced mammary tumors. J. Nucl. Med. 22, 42-47.
18. 77Br]-11 beta-methoxyestradiol- 17 beta, two estrogen receptor-binding radiopharmaceuticals. Int. J. Appl. Radiat. Isot. 33, 545-551.
19. 77Br]bromo- 11 beta-methoxyestradiol-17 beta: agammaemitting estrogen imaging agent with high uptake and retention by target organs. J. Nucl. Med. 23, 411-419.
20. Adam, M. J., Ruth, T. J., Homma, Y., and Pate, B. D. (1985) Radiobromination of aromatic compounds by cleavage of aryltin bonds. Int. J. Appl. Radiat. Isot. 36, 935-937.
21. Moerlein, S. M., and Coenen, H. H. (1985) Regiospecific no-carrier-added radiobromination and radioiodination of aryltrim-ethyl group IVb organometallics. J. Chem. Soc., Perkin Trans. 1941-1947.
22. Mohammad, A., and Liebhafsky, H. A. (1934) The kinetics of the reduction of hydrogen peroxide by the halides. J. Am. Chem. Soc. 56, 1680-1685.
23. Fortnum, D. H., Battaglia, C. J., Cohen, S. R., and Edwards, J. O. (1960) The kinetics of the oxidation of halide ions by monosubstituted peroxides. J. Am. Chem. Soc. 82, 778-782.
24. Wajon, J. E., and Morris, J. C. (1982) Rates of formation of N-bromo amines in aqueous solution. Inorg. Chem. 21, 4258-4263.
25. Inman, G. W., Jr., and Johnson, J. D. (1984) Kinetics of monobromamine disproportionation-dibromamine formation in aqueous ammonia solutions. Environ. Sci. Technol. 18, 219-224.
26. Mellegaard-Waetzig, S. R., Wang, C., and Tunge, J. A. (2006) Selenium-catalyzed oxidative halogenation. Tetrahedron 62, 7191-7198.
27. 76Br]BMK-152: a PET ligand for corticotropin-releasing hormone (CRH) type 1 receptor. J. Label. Compd. Radiopharm. 50, S56.
28. Ogata, Y., and Aoki, K. (1966) Haloacyloxylation. II. addition of bromine or chlorine to propylene in the presence of peracetic acid. J. Ors. Chem. 31, 4181-4183.
29. Barnett, J. R., Andrews, L. J., and Keefer, R. M. (1972) Trifluoroacetyl hypohalites as aromatic halogenating agents. J. Am. Chem. Soc. 94, 6129-6134.
30. Voudrias, E. A., and Reinhard, M. (1988) Reactivities of hypochlorous and hypobromous acid, chlorine monoxide, hypobromous acidium ion, chlorine, bromine, and bromine chloride in electrophilic aromatic substitution reactions with p-xylene in water. Environ. Sci. Technol. 22, 1049-1056.
31. Derbyshire, D. H., and Waters, W. A. (1950) Significance of bromine cation in aromatic substitution. I. Kinetic evidence. J. Chem. Soc. 564-573.
32. Wang, T. X., Kelley, M. D., Cooper, J. N., Beckwith, R. C., and Margerum, D. W. (1994) Equilibrium, kinetic, and UV-spectral characteristics of aqueous bromine chloride, bromine, and chlorine species. Inors. Chem. 33, 5872-5878.
33. Sander, R., and Crutzen, P. J. (1996) Model study indicating halogen activation and ozone destruction in polluted air masses transported to the sea. J. Geovhvs. Res. 101, 9121-9138.
34. Farkas, L., Lewin, M., and Bloch, R. (1949) The reaction between hypochlorite and bromides. J. Am. Chem. Soc. 71, 1988-1991.
35. 2 radicals in aquesous solution. J Phys. Chem. Ref. Data 14, 1041-1100.
36. Eigen, M., and Kustin, K. (1962) The kinetics of halogen hydrolysis. J. Am. Chem. Soc. 84, 1355-1361.
37. Liebhafsky, H. A. (1934) The equilibrium constant of the bromine hydrolysis and its variation with temperature. J. Am. Chem. Soc. 56, 1500-1505.
38. Gilow, H. M., and Ridd, J. H. (1973) Mechanism of aromatic bromination by hypobromous acid in aqueous perchloric acid. Kinetic evidence against the prior formation of 'positive bromine'. J. Chem. Soc., Perkin Trans. 2, 1321-1327.
39. Kumar, K., and Margerum, D. W. (1987) Kinetics and mechanism of general-acid-assisted oxidation of bromide by hypochlorite and hypochlorous acid. Inors. Chem. 26, 2706-2711.
40. De la Mare, P. B. D. (1976) Electrophilic halogenation: reaction pathways involving attack by electrophilic halogens on unsaturated compounds, p 125, Chapter 7, Cambridge University Press, London.
41. 76Br] bromometaraminol, two potential radiotracers for the study of the myocardial norepinephrine neuronal reuptake system with PET. J. Label. Compd. Radiop-harm. 39, 803-816.
42. Zhou, D., Sharp, T. L., Fettig, N. M., Lee, H., Lewis, J. S., Katzenellenbogen, J. A., and Welch, M. J. (2008) Evaluation of a bromine-76-labeled progestin 16a,17a-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies. Nucl. Med. Biol. 35, 655-663.
43. 125I-containing acylating agent. Biochem. J. 133, 529-539.